Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief?
Barliz Waissengrin, Yasmin Leshem, Marwa Taya, et al.
European Journal of Cancer (2022) Vol. 180, pp. 52-61
Closed Access | Times Cited: 21

Showing 21 citing articles:

Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline
Ilana M. Braun, Kari Bohlke, Donald I. Abrams, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 13, pp. 1575-1593
Closed Access | Times Cited: 20
The impact of cannabis on immune checkpoint inhibitor therapy: a systematic review of immunomodulatory effects of cannabis in patients with and without cancer
Caroline Behling-Hess, Grant Simonson, Talya Salz, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 3
Closed Access | Times Cited: 1
Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
MariaLuisa Vigano, Lixing Wang, Alia As’sadiq, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies – Current status of preclinical and clinical research
Robert Ramer, Burkhard Hinz
Pharmacology & Therapeutics (2025), pp. 108851-108851
Closed Access
Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview
Jingjing Li, Xuan-Fu Xu
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1527-1540
Open Access | Times Cited: 11
Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers
Gary L. Ellison, Kathy J. Helzlsouer, Sonia Rosenfield, et al.
JNCI Monographs (2024) Vol. 2024, Iss. 66, pp. 202-217
Open Access | Times Cited: 4
Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data
Courtney H. Coschi, Keyue Ding, Justin Tong, et al.
Immunotherapy (2025), pp. 1-12
Closed Access
Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs
Thomas Herdegen, Ingolf Cascorbi
Deutsches Ärzteblatt international (2023)
Open Access | Times Cited: 9
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours
Nina Fuller-Shavel, Jonathan Krell
Current Oncology Reports (2024) Vol. 26, Iss. 2, pp. 164-174
Open Access | Times Cited: 3
Immunotherapy and Cannabis: A Harmful Drug Interaction or Reefer Madness?
Brian J. Piper, Maria Tian, Pragosh Saini, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1245-1245
Open Access | Times Cited: 3
The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine
Magdalena Skórzewska, Katarzyna Gęca
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1334-1348
Open Access | Times Cited: 3
Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?
Arailym Sarsembayeva, Rudolf Schicho
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Cannabidiol Enhances Atezolizumab Efficacy by Upregulating PD-L1 Expression via the cGAS–STING Pathway in Triple-Negative Breast Cancer Cells
Bu Gyeom Kim, Bo Ram Kim, Dae Yeong Kim, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 12, pp. 1796-1807
Open Access | Times Cited: 2
Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges
Hannah R. Wardill, Luke T. Wooley, Olivia M. Bellas, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 1, pp. 19-30
Open Access | Times Cited: 6
Immunotherapy and Cannabis: A Harmful Drug Interaction or Reefer Madness?
Brian J. Piper, Maria Tian, Pragosh Saini, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Phytocannabinoids as Chemotherapy Adjuncts – a User Guide
Gerhard Nahler
(2024)
Open Access | Times Cited: 1
Phytocannabinoids as Chemotherapy Adjuncts—A Review for Users
Gerhard Nahler
Onco (2024) Vol. 4, Iss. 4, pp. 287-321
Open Access | Times Cited: 1
Association between cannabis use and clinical outcomes in patients with solid malignancies receiving immune checkpoint inhibitors
Tarik Hadid, Adam Biedny, Hirva Mamdani, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2024) Vol. 12
Open Access | Times Cited: 1
Impact of Marijuana Use on Lung Health
Joanne M. Bando, Donald P. Tashkin, Igor Barjaktarević
Seminars in Respiratory and Critical Care Medicine (2024) Vol. 45, Iss. 05, pp. 548-559
Closed Access
Cannabis in der Onkologie – viel Rauch um nichts?
Anton Burkhard‐Meier, Constanze Rémi, Lars H. Lindner, et al.
TumorDiagnostik & Therapie (2023) Vol. 44, Iss. 10, pp. 689-695
Closed Access
Integrating Therapies: A Rational, Personalised Approach to Metastatic Disease
Penny Kechagioglou, Nina Fuller-Shavel
(2023), pp. 95-112
Closed Access
Page 1

Scroll to top